People with chronic chest pain who received a coronary sinus reducer (CSR)—a stent thought to increase the amount of oxygen-rich blood flowing to the heart muscle—experienced significant reductions in the daily number ...
Apr 8, 2024
0
2
Trial results presented today revealed a promising therapy for patients experiencing angina due to coronary microvascular dysfunction (CMD). The results of the study were presented today as feature clinical research during ...
May 14, 2020
0
1
An analysis of data from the entire development program consisting of three trials assessing the feasibility of using a stem cell therapy (CD34+ cells) to treat patients with the most severe cases of angina, refractory angina ...
May 11, 2017
0
3
Lipoprotein apheresis, a therapy normally used to filter excess cholesterol from the blood of patients with familial hypercholesterolemia, may have a new role in patients with refractory angina.
Aug 29, 2016
0
0
(HealthDay)—A stent-like device placed in the coronary sinus may benefit patients with refractory angina, according to a small clinical trial published in the Feb. 5 issue of the New England Journal of Medicine. The Reducer ...
Feb 5, 2015
0
3
Death rates associated with patients with refractory angina, or chronic chest pain, are lower than previously considered; therefore, physicians should focus on relieving the chest pain symptoms and improving the quality of ...
May 15, 2013
0
0
Tens of thousands of Canadians seek emergency services and are referred for angiograms each year to investigate sources of chest pain. For approximately half a million Canadians, chronic chest pain – or, specifically, ...
Apr 19, 2012
0
0
(HealthDay) -- Cardiac shock wave therapy (CSWT) can significantly improve symptoms, ischemic threshold during exercise, and specific quality-of-life parameters for patients with chronic refractory angina pectoris, according ...
Mar 30, 2012
0
0
